<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00817622</url>
  </required_header>
  <id_info>
    <org_study_id>27-4955</org_study_id>
    <nct_id>NCT00817622</nct_id>
  </id_info>
  <brief_title>Effects of EPA and Vitamin E on Leptin, Adiponectin and Enzymatic Antioxidants in Type 2 DM</brief_title>
  <acronym>EPA</acronym>
  <official_title>Effects of EPA Alone and Combined With Vitamin E on Blood Leptin, Adiponectin and Enzymatic Antioxidants Levels in Type II Diabetic Patients; A Randomized, Double-Blind, Placebo-Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tehran University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tehran University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate efficacy and safety of EPA(Eicosapentaenoic
      Acid)alone and with VitE in diabetic patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized, double-blind, placebo-controlled, parallel-group study design After a 12weeks,
      subjects with type II DM will be randomized to receive either 2000 mg pearl EPA per day plus
      a double-blinded matching placebo (1 corn oil pearls per day) for 12 weeks OR 400 mg VitE
      pearl plus double-blinded per day plus a double-blinded matching placebo (4 corn oil pearls
      per day) for 12 weeks OR 2000 mg pearl EPA per day plus a double-blinded matching 400 mg VitE
      pearl OR placebo(4corn oil pearls per day plus 1 corn oil pearls per day )for 12 weeks.The
      total dose of EPA pearl will be 2000 mg per day (with the EPA or matching placebo corn oil
      doses remaining at 4 pearls per day) and The total dose of VitE pearl will be 400 mg per day
      (with the VitE or matching placebo corn oil doses remaining at 1 pearls per day).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in leptin and adiponectin after 12 Weeks</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">129</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo, Placebo :
Placebo pearls,500 mg QID for 12 Weeks (2000 mg corn oil per day) Placebo pearl + corn oil 400 mg per day for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EPA, Placebo :
EPA pearls,500 mg QID for 12 Weeks (2000 mg per day),From MINAMINUTRITION Company(Belgium)+ Placebo pearl ,corn oil 400 mg per day for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo ,Vitamin E :
Placebo pearls,500 mg QID for 12 Weeks (2000 mg corn oil per day)+ Vitamin E pearls, 400 mg from DANA Company(IRAN) per day for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EPA, Vitamin E :
EPA pearls,500 mg QID From MINAMINUTRITION Company(Belgium) for 12 Weeks (2000 mg EPA per day)+ Vitamin E pearls, 400 mg from DANA Company ( IRAN) per day for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>EPA, Vitamin E</intervention_name>
    <description>EPA pearls, 500 mg QID for 12 Weeks (2000 mg per day) Vitamin E pearls, 400 mg per day for 12 weeks</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
    <arm_group_label>C</arm_group_label>
    <arm_group_label>D</arm_group_label>
    <other_name>Plus EPA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DM Type II.

          -  Antidiabetic drug therapy which cannot be stopped.

          -  History of DM about 2-15 year.

          -  Age between 30-55 year.

          -  No History of circulatory, thyroid, pulmonary, liver, kidney, cancer.

        Exclusion Criteria:

          -  DM Type I.

          -  Nephropathy.

          -  Retinopathy.

          -  Cancer.

          -  Thyroid disease.

          -  Renal failure.

          -  pulmonary disease

          -  MI.

          -  CHD.

          -  Liver disease,
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmood Djalali, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Tehran University of Medical Sciences, school of Public Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shokooh Sarbolouki, PhD Student</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tehran University of Medical Sciences, School of Public Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmad Reza - Dorosti, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Tehran University of Medical Sciences,School of Public Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tehran University Of Medical Sciences</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2009</study_first_submitted>
  <study_first_submitted_qc>January 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2009</study_first_posted>
  <last_update_submitted>November 17, 2009</last_update_submitted>
  <last_update_submitted_qc>November 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2009</last_update_posted>
  <responsible_party>
    <name_title>Professor Mahmood Djalali</name_title>
    <organization>Tehran University of Medical Sciences</organization>
  </responsible_party>
  <keyword>diabetes mellitus type 2</keyword>
  <keyword>EPA</keyword>
  <keyword>leptin</keyword>
  <keyword>adiponectin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

